EVGN - Evogene Ltd. Market Capitalization
The financial price visualization for Evogene Ltd. (EVGN) on GURU.Markets demonstrates the price action of the Israeli computational biology developer, whose success relies on scaling genome editing systems and partner payments. Market capitalization stands at 0.01, while the company maintains its market position through neural network analysis of plant resilience. Cloud clusters ensure calculation stability and are being systematically expanded to provide uninterrupted operations for geneticists.
Analytical breakdowns for Evogene Ltd.
The market value dynamics of Evogene Ltd. (EVGN) reflect the investment valuation of the CPB AI platform's potential in plant breeding. The issuer's market capitalization represents the total market volume of the business, calculated based on current share prices. This indicator measures the company's total value, allowing for an assessment of the asset's liquidity and risk. For Evogene Ltd. (EVGN), this metric confirms the value of its unique neural network developments regarding crop resilience. The stability of this metric indicates strong market confidence in the company's technological advantage.
